Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2013 Financial Results and HCV Pipeline Update on Wednesday, October 30, 2013
October 28, 2013 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Oct. 28, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that the Company's third quarter 2013 financial results will be released after close of...
Idenix Pharmaceuticals Announces Nucleotide Prodrug Program Poster Presentation at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting
October 01, 2013 14:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2013 Financial Results
August 07, 2013 07:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 7, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals, Inc. to Hold Second Quarter and Six Month 2013 Financial Results Conference Call on Wednesday, August 7, 2013
August 06, 2013 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that the Company's second quarter 2013 financial results will be released before market...
Idenix Pharmaceuticals Announces Update on Development Program for Its Lead HCV Nucleotide Prodrug Candidate, IDX20963
June 20, 2013 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., June 20, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at the Wells Fargo Securities 2013 Healthcare Conference
June 11, 2013 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., June 11, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the Wells Fargo Securities...
Idenix Pharmaceuticals Appoints Charles Rowland to Its Board of Directors
June 10, 2013 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., June 10, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Announces Samatasvir (IDX719) Poster Presentations at the Asian Pacific Association for the Study of the Liver (APASL) Conference
June 06, 2013 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., June 6, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals Announces Initiation of Phase II All-Oral Combination Study of Samatasvir (IDX719) and Simeprevir (TMC435) for the Treatment of Hepatitis C Virus (HCV) Infection
May 30, 2013 08:00 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 30, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human...
Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
May 08, 2013 16:05 ET
|
Idenix Pharmaceuticals
CAMBRIDGE, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that Idenix management will present a corporate overview at the Bank of America Merrill...